XUGIKRA
LIVE

Serial Number

79399368

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Mar 25, 2024

Add to watchlist:

No watchlists yet
View on USPTO

XUGIKRA Trademark

Serial Number: 79399368 • Registration: 7637094

XUGIKRA is a trademark filed by NOVARTIS AG on March 25, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,172 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 25, 2024

Registration Date

January 7, 2025

Published for Opposition

November 19, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 18, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 3, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 3, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 6, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 7, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 7, 2025 R.PR
PUBLISHED FOR OPPOSITION
Nov 19, 2024 PUBO
NOTICE OF PUBLICATION
Nov 13, 2024 NPUB
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 15, 2024 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 26, 2024 CNSA
ASSIGNED TO EXAMINER
Sep 25, 2024 DOCK
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 30, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 30, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 30, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 30, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 30, 2024 COAR
APPLICATION FILING RECEIPT MAILED
Jul 22, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 22, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 9, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 4, 2024 REPR